drugset / Trial / NCT00122291

A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer

NCT00122291 ↗

Phase 2 Unknown 66 enrolled Alberta Health services
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to study the efficacy of preoperative radiation therapy and capecitabine in locally advanced rectal cancer.

Timeline

Start
2002-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — Oral